IBDEI343 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,49698,1,3,0)
;;=3^Chronic Kidney Disease,Stage 5
;;^UTILITY(U,$J,358.3,49698,1,4,0)
;;=4^N18.5
;;^UTILITY(U,$J,358.3,49698,2)
;;=^5015606
;;^UTILITY(U,$J,358.3,49699,0)
;;=N18.6^^191^2478^22
;;^UTILITY(U,$J,358.3,49699,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49699,1,3,0)
;;=3^End Stage Renal Disease
;;^UTILITY(U,$J,358.3,49699,1,4,0)
;;=4^N18.6
;;^UTILITY(U,$J,358.3,49699,2)
;;=^303986
;;^UTILITY(U,$J,358.3,49700,0)
;;=J96.11^^191^2478^19
;;^UTILITY(U,$J,358.3,49700,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49700,1,3,0)
;;=3^Chronic Respiratory Failure w/ Hypoxia
;;^UTILITY(U,$J,358.3,49700,1,4,0)
;;=4^J96.11
;;^UTILITY(U,$J,358.3,49700,2)
;;=^5008351
;;^UTILITY(U,$J,358.3,49701,0)
;;=J44.9^^191^2478^12
;;^UTILITY(U,$J,358.3,49701,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49701,1,3,0)
;;=3^COPD,Unspec
;;^UTILITY(U,$J,358.3,49701,1,4,0)
;;=4^J44.9
;;^UTILITY(U,$J,358.3,49701,2)
;;=^5008241
;;^UTILITY(U,$J,358.3,49702,0)
;;=E44.0^^191^2478^29
;;^UTILITY(U,$J,358.3,49702,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49702,1,3,0)
;;=3^Moderate Protein-Calorie Malnutrition
;;^UTILITY(U,$J,358.3,49702,1,4,0)
;;=4^E44.0
;;^UTILITY(U,$J,358.3,49702,2)
;;=^5002787
;;^UTILITY(U,$J,358.3,49703,0)
;;=E43.^^191^2478^30
;;^UTILITY(U,$J,358.3,49703,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49703,1,3,0)
;;=3^Severe Protein-Calorie Malnutrition
;;^UTILITY(U,$J,358.3,49703,1,4,0)
;;=4^E43.
;;^UTILITY(U,$J,358.3,49703,2)
;;=^5002786
;;^UTILITY(U,$J,358.3,49704,0)
;;=R64.^^191^2478^13
;;^UTILITY(U,$J,358.3,49704,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49704,1,3,0)
;;=3^Cachexia
;;^UTILITY(U,$J,358.3,49704,1,4,0)
;;=4^R64.
;;^UTILITY(U,$J,358.3,49704,2)
;;=^17920
;;^UTILITY(U,$J,358.3,49705,0)
;;=I10.^^191^2478^23
;;^UTILITY(U,$J,358.3,49705,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49705,1,3,0)
;;=3^Essential (Primary) Hypertension
;;^UTILITY(U,$J,358.3,49705,1,4,0)
;;=4^I10.
;;^UTILITY(U,$J,358.3,49705,2)
;;=^5007062
;;^UTILITY(U,$J,358.3,49706,0)
;;=I25.10^^191^2478^11
;;^UTILITY(U,$J,358.3,49706,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49706,1,3,0)
;;=3^CAD w/o Angina Pectoris
;;^UTILITY(U,$J,358.3,49706,1,4,0)
;;=4^I25.10
;;^UTILITY(U,$J,358.3,49706,2)
;;=^5007107
;;^UTILITY(U,$J,358.3,49707,0)
;;=E78.2^^191^2478^28
;;^UTILITY(U,$J,358.3,49707,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49707,1,3,0)
;;=3^Mixed Hyperlipidemia
;;^UTILITY(U,$J,358.3,49707,1,4,0)
;;=4^E78.2
;;^UTILITY(U,$J,358.3,49707,2)
;;=^78424
;;^UTILITY(U,$J,358.3,49708,0)
;;=I48.0^^191^2478^8
;;^UTILITY(U,$J,358.3,49708,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49708,1,3,0)
;;=3^Atrial Fibrillation,Paroxysmal
;;^UTILITY(U,$J,358.3,49708,1,4,0)
;;=4^I48.0
;;^UTILITY(U,$J,358.3,49708,2)
;;=^90473
;;^UTILITY(U,$J,358.3,49709,0)
;;=I48.11^^191^2478^6
;;^UTILITY(U,$J,358.3,49709,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49709,1,3,0)
;;=3^Atrial Fibrillation,Longstanding Persistent
;;^UTILITY(U,$J,358.3,49709,1,4,0)
;;=4^I48.11
;;^UTILITY(U,$J,358.3,49709,2)
;;=^5158046
;;^UTILITY(U,$J,358.3,49710,0)
;;=I48.19^^191^2478^7
;;^UTILITY(U,$J,358.3,49710,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49710,1,3,0)
;;=3^Atrial Fibrillation,Other Persistent
;;^UTILITY(U,$J,358.3,49710,1,4,0)
;;=4^I48.19
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI343 3745 printed Apr 09, 2024@21:15:16 Page 2
IBDEI343 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,49698,1,3,0)
+2 ;;=3^Chronic Kidney Disease,Stage 5
+3 ;;^UTILITY(U,$J,358.3,49698,1,4,0)
+4 ;;=4^N18.5
+5 ;;^UTILITY(U,$J,358.3,49698,2)
+6 ;;=^5015606
+7 ;;^UTILITY(U,$J,358.3,49699,0)
+8 ;;=N18.6^^191^2478^22
+9 ;;^UTILITY(U,$J,358.3,49699,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,49699,1,3,0)
+12 ;;=3^End Stage Renal Disease
+13 ;;^UTILITY(U,$J,358.3,49699,1,4,0)
+14 ;;=4^N18.6
+15 ;;^UTILITY(U,$J,358.3,49699,2)
+16 ;;=^303986
+17 ;;^UTILITY(U,$J,358.3,49700,0)
+18 ;;=J96.11^^191^2478^19
+19 ;;^UTILITY(U,$J,358.3,49700,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,49700,1,3,0)
+22 ;;=3^Chronic Respiratory Failure w/ Hypoxia
+23 ;;^UTILITY(U,$J,358.3,49700,1,4,0)
+24 ;;=4^J96.11
+25 ;;^UTILITY(U,$J,358.3,49700,2)
+26 ;;=^5008351
+27 ;;^UTILITY(U,$J,358.3,49701,0)
+28 ;;=J44.9^^191^2478^12
+29 ;;^UTILITY(U,$J,358.3,49701,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,49701,1,3,0)
+32 ;;=3^COPD,Unspec
+33 ;;^UTILITY(U,$J,358.3,49701,1,4,0)
+34 ;;=4^J44.9
+35 ;;^UTILITY(U,$J,358.3,49701,2)
+36 ;;=^5008241
+37 ;;^UTILITY(U,$J,358.3,49702,0)
+38 ;;=E44.0^^191^2478^29
+39 ;;^UTILITY(U,$J,358.3,49702,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,49702,1,3,0)
+42 ;;=3^Moderate Protein-Calorie Malnutrition
+43 ;;^UTILITY(U,$J,358.3,49702,1,4,0)
+44 ;;=4^E44.0
+45 ;;^UTILITY(U,$J,358.3,49702,2)
+46 ;;=^5002787
+47 ;;^UTILITY(U,$J,358.3,49703,0)
+48 ;;=E43.^^191^2478^30
+49 ;;^UTILITY(U,$J,358.3,49703,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,49703,1,3,0)
+52 ;;=3^Severe Protein-Calorie Malnutrition
+53 ;;^UTILITY(U,$J,358.3,49703,1,4,0)
+54 ;;=4^E43.
+55 ;;^UTILITY(U,$J,358.3,49703,2)
+56 ;;=^5002786
+57 ;;^UTILITY(U,$J,358.3,49704,0)
+58 ;;=R64.^^191^2478^13
+59 ;;^UTILITY(U,$J,358.3,49704,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,49704,1,3,0)
+62 ;;=3^Cachexia
+63 ;;^UTILITY(U,$J,358.3,49704,1,4,0)
+64 ;;=4^R64.
+65 ;;^UTILITY(U,$J,358.3,49704,2)
+66 ;;=^17920
+67 ;;^UTILITY(U,$J,358.3,49705,0)
+68 ;;=I10.^^191^2478^23
+69 ;;^UTILITY(U,$J,358.3,49705,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,49705,1,3,0)
+72 ;;=3^Essential (Primary) Hypertension
+73 ;;^UTILITY(U,$J,358.3,49705,1,4,0)
+74 ;;=4^I10.
+75 ;;^UTILITY(U,$J,358.3,49705,2)
+76 ;;=^5007062
+77 ;;^UTILITY(U,$J,358.3,49706,0)
+78 ;;=I25.10^^191^2478^11
+79 ;;^UTILITY(U,$J,358.3,49706,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,49706,1,3,0)
+82 ;;=3^CAD w/o Angina Pectoris
+83 ;;^UTILITY(U,$J,358.3,49706,1,4,0)
+84 ;;=4^I25.10
+85 ;;^UTILITY(U,$J,358.3,49706,2)
+86 ;;=^5007107
+87 ;;^UTILITY(U,$J,358.3,49707,0)
+88 ;;=E78.2^^191^2478^28
+89 ;;^UTILITY(U,$J,358.3,49707,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,49707,1,3,0)
+92 ;;=3^Mixed Hyperlipidemia
+93 ;;^UTILITY(U,$J,358.3,49707,1,4,0)
+94 ;;=4^E78.2
+95 ;;^UTILITY(U,$J,358.3,49707,2)
+96 ;;=^78424
+97 ;;^UTILITY(U,$J,358.3,49708,0)
+98 ;;=I48.0^^191^2478^8
+99 ;;^UTILITY(U,$J,358.3,49708,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,49708,1,3,0)
+102 ;;=3^Atrial Fibrillation,Paroxysmal
+103 ;;^UTILITY(U,$J,358.3,49708,1,4,0)
+104 ;;=4^I48.0
+105 ;;^UTILITY(U,$J,358.3,49708,2)
+106 ;;=^90473
+107 ;;^UTILITY(U,$J,358.3,49709,0)
+108 ;;=I48.11^^191^2478^6
+109 ;;^UTILITY(U,$J,358.3,49709,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,49709,1,3,0)
+112 ;;=3^Atrial Fibrillation,Longstanding Persistent
+113 ;;^UTILITY(U,$J,358.3,49709,1,4,0)
+114 ;;=4^I48.11
+115 ;;^UTILITY(U,$J,358.3,49709,2)
+116 ;;=^5158046
+117 ;;^UTILITY(U,$J,358.3,49710,0)
+118 ;;=I48.19^^191^2478^7
+119 ;;^UTILITY(U,$J,358.3,49710,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,49710,1,3,0)
+122 ;;=3^Atrial Fibrillation,Other Persistent
+123 ;;^UTILITY(U,$J,358.3,49710,1,4,0)
+124 ;;=4^I48.19
